Salmeterol, fixed dose combinations, LABA ICS in patients

• Research type

  Research Study

• Full title

  A Single Dose, Randomised, 5-Way Complete Crossover, Placebo Controlled, Double Dummy, Pharmacodynamic Clinical Trial Assessing Two Fixed Dose Combinations of Long Acting Beta Agonist (LABA) and Inhaled Corticosteroid (ICS).

• IRAS ID

  139720

• Contact name

  Muna Albayaty

• Contact email

  muna.albayaty@parexel.com

• Sponsor organisation

  Almiral, S.A.

• Eudract number

  2013-002939-25

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  14/SC/0009

• Date of REC Opinion

  3 Feb 2014

• REC opinion

  Favourable Opinion